We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

18 hedge funds and large institutions have $25.7M invested in Tonix Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0% → 0% (-0%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

18% less funds holding

Funds holding: 22 → 18 (-4)

41% less capital invested

Capital invested by funds: $43.7M → $25.7M (-$17.9M)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
18
Holders Change
-4
Holders Change %
-18.18%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.99M
2
BlackRock
BlackRock
New York
+$918K
3
State Street
State Street
Massachusetts
+$306K
4
CM
Crestline Management
Texas
+$153K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$153K

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.21M
2
Prudential Financial
Prudential Financial
New Jersey
-$1.68M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$366K
4
AFM
Anson Funds Management
Texas
-$309K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$306K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
26
California State Teachers Retirement System (CalSTRS)
California
$50K – – –
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$43K – – –
State Board of Administration of Florida Retirement System
28
State Board of Administration of Florida Retirement System
Florida
$40K – – –
EMG
29
ETF Managers Group
New Jersey
$33K – – –
ProShare Advisors
30
ProShare Advisors
Maryland
$33K – – –
Invesco
31
Invesco
Georgia
$32K – – –
SG Americas Securities
32
SG Americas Securities
New York
$31K – – –
Jane Street
33
Jane Street
New York
$30K – – –
VOYA Investment Management
34
VOYA Investment Management
Georgia
$29K – – –
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$25.7K – – –
AllianceBernstein
36
AllianceBernstein
Tennessee
$23K – – –
Citigroup
37
Citigroup
New York
$21K – – –
Principal Financial Group
38
Principal Financial Group
Iowa
$18K – – –
TRCT
39
Tower Research Capital (TRC)
New York
$18K – – –
SO
40
STRS Ohio
Ohio
$17K – – –
HFS
41
Hantz Financial Services
Michigan
$13K – – –
Wells Fargo
42
Wells Fargo
California
$13K – – –
WFS
43
Walker Financial Services
Kentucky
$12.9K – – –
AB
44
Amalgamated Bank
New York
$12K – – –
AF
45
Amalgamated Financial
New York
$12K – – –
PHK
46
Point72 Hong Kong
Hong Kong
$10K -$153K -1 Closed
T. Rowe Price Associates
47
T. Rowe Price Associates
Maryland
$10K – – –
Victory Capital Management
48
Victory Capital Management
Texas
$10K – – –
CS
49
Credit Suisse
Switzerland
$9K – – –
Legal & General Group
50
Legal & General Group
United Kingdom
$9K – – –
1
2
3 4

TNXP Hedge Fund Activity: Q1 2022 in Review

18 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q1 2022, worth a combined $25.7M — down 41% from $43.7M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TNXP and 1 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.99M. The largest seller was D.E. Shaw & Co, cutting an estimated $3.21M.

  • 18 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q1 2022, down from 22 in Q4 2021.
  • Funds reported $25.7M of Tonix Pharmaceuticals stock for Q1 2022, down 41% quarter-over-quarter.
  • 1 fund opened new Tonix Pharmaceuticals positions in Q1 2022 and 5 closed out, a net change of -4 holders.
  • The largest Tonix Pharmaceuticals buyer in Q1 2022 was Renaissance Technologies, an estimated $1.99M added.
  • The largest Tonix Pharmaceuticals seller in Q1 2022 was D.E. Shaw & Co, an estimated $3.21M sold.

Based on aggregated 13F filings for Q1 2022.